Evidence map›Paper›PMID 27994655›Full record

ArticleJournal of Cancer2016

Alteration status and prognostic value of MET in head and neck squamous cell carcinoma.

Yoon Ah Cho, Eun Kyung Kim, Su Jin Heo, Byoung Chul Cho, Hye Ryun Kim, Ji Myung Chung, Sun Och Yoon

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Head and Neck Squamous Cell Carcinoma: Epigenetic Landscape.Diagnostics (Basel, Switzerland) · 2020
    Review
  9. Changes in oncogenic protein levels in peri-implant oral malignancy: a case report.Maxillofacial plastic and reconstructive surgery · 2019
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yoon Ah ChoDepartment of Pathology, Yonsei University College of Medicine, Seoul, Korea.
Eun Kyung KimDepartment of Pathology, Yonsei University College of Medicine, Seoul, Korea.
Su Jin HeoYonsei Cancer Center, Division of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea.
Byoung Chul ChoYonsei Cancer Center, Division of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea.
Hye Ryun KimYonsei Cancer Center, Division of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea.
Ji Myung ChungYonsei University College of Medicine, Seoul, Korea.
Sun Och YoonDepartment of Pathology, Yonsei University College of Medicine, Seoul, Korea.
Yonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The MET pathway plays a key role in various cancers, and its inhibition represents a potential treatment target. However, appropriate biomarkers are needed to facilitate the selection of patients who would benefit from MET inhibiting therapy. We herein conducted a robust confirmatory evaluation of the

Indexed as

c-Met proteinHead and neck squamous cell carcinomaMET genePrognosis

Identifiers

PMID27994655
PMCPMC5166528
OpenAlexW2553024103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.